Skip to main content

Advertisement

SpringerLink
Log in

Peak bone mass and osteoporosis prevention

  • Session III: Peak Bone Mass And Whole Body Composition
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

The Incidence of osteoporotic fractures increases with advancing age. Despite advances in therapy, reversal of bone loss in established osteoporosis remains problematic and deformities and disability due to fractures often persist. Therefore the logical approach to osteoporosis treatment is preventive. Risk of fracture is determined largely by bone density, which is the end result of peak value achieved at skeletal maturity and subsequent age- and menopause-related bone loss. Thus the determinants of peak bone density and bone loss require full characterization. Environmental and lifestyle factors are important determinants of bone density, particularly physical activity and diet. For example, muscle strength and physical fitness predict bone density, so that regular moderate exercise may help maintain bone mass but probably does not reverse loss. Long-term calcium intake appears to be important for achievement and maintenance of peak bone density, especially in males. Smoking and excessive alcohol intake are deleterious to bone mass. Cultural norms in diet, lifestyle and physical activity obviously have an impact on bone density. Genetic factors have a strong role in determining the wide range in ‘normal’ peak bone mass. Moreover we have found strong genetic determinants of rates of change of bone mass in the lumbar spine and similar trends for sites in the femoral neck. We have shown previously that genetic factors influence bone turnover indices, particularly osteocalcin. Investigating these relationships with restriction fragment length polymorphisms, we have identified variants of the vitamin D receptor gene which predict osteocalcin levels and presumably bone turnover. This genetic mechanism may explain some of the normal variations in bone turnover and thus peak bone mass and subsequent bone loss. Morbidity and disability from osteoporosis are incompletely reversible. Therefore prevention is the major current strategic aim, directed at the achievement and maintenance of peak bone density. Although lifestyle and environmental factors are important, improved understanding of genetic mechanisms of regulation of bone turnover will be central to the future development of improved strategies for prevention and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ott SM, Chestnust C III. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 1989;110:267–74.

    Google Scholar 

  2. Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura S, Cohn SH. Calcitriol in the treatment of postmenopausal osteoporosis. AM J Med 1988;84:401–8.

    Google Scholar 

  3. Gallagher JC, Riggs BL. Calcitriol for postmenopausal osteoporosis [letter]. Ann Intern Med 1989;111.

  4. Shiraki M, Ito H, Orimo H. The effect of 1,25 [OH]2D3 on bone mineral content in senile osteoporosis: a dose-finding study. Nippon Naibunpi Gakkai Zasshi 1989;65:1253–63.

    Google Scholar 

  5. Cohn SH, Dombrowski CS, Hauser W, Klopper J, Atkins HL. Effects of procine calcitonin on calcium metabolism in osteoporosis. J Clin Endocrinol Metab 1971;33,719–28.

    Google Scholar 

  6. Gruber HE, Ivey JL, Bayling DJ, Mathews M, Nelp WB, Sisom K, Chesnut C. Long term calcitonin therapy in postmenopausal osteoporosis. Metabolim 1984;33:295–303.

    Google Scholar 

  7. McIntyre I, Stevenson JC, Whitehead MI, Wimalawansa SJ, Banks LM, Healy MJR. Calcitonin for the prevention of postmenopausal bone loss. Lancet 1988;1:900–2.

    Google Scholar 

  8. Overgaard K, Riis BJ, Christiansen C, Hansen MA. Effect of salcatonin given intranasally on early postmenopausal bone loss. BMJ 1989;299:477–9.

    Google Scholar 

  9. Need AG, Horowitz M, Bridges A, Morris HA, Nordin BE. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women. Arch Intern Med 1989;149:57–60.

    Google Scholar 

  10. Riggs GL, Hodgson SF, O'Fallon WM, Chao EYS, Wahner HW, Muhs JM, et al. Effects of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 1990;322:802–9.

    Google Scholar 

  11. Hedlund LR, Gallagher JC. Increased incidence of hip fracture in osteoporotic women treated sodium fluoride. J Bone Miner Res 1989;4:223–5.

    Google Scholar 

  12. Nagant de Deuxchaisnes Devogelaer JP, Depresseux G, Malghem J, Maldague B. Treatment of the vertebral crush fracture syndrome with enteric-coated sodium fluoride tablets and calcium supplements. J Bone Miner Res 1990;5:5s-26s.

    Google Scholar 

  13. Pak CY, Sakhaee K, Zerwekh JE. Effect of intermittent therapy with a slow release fluoride preparation. J Bone Miner Res 1990;5:149s-155s.

    Google Scholar 

  14. Kragstrup J, Shijie Z, Mosekilde L, Melsen F. Effects of sodium fluoride, vitamin D, and calcium on cortical bone remodelling in osteoporotic patients. Calcif Tissue Int 1989;45:337–41.

    Google Scholar 

  15. Storm, T, Thamsbourg G, Steiniche T, Genant HK, Sorensen OH. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990;322:265–71.

    Google Scholar 

  16. Watts NB, Harris ST, Genant HK, Wasnich RD, Millder PD, Jackson RD, et al. Intermittent cyclical etidronate therapy of postmenopausal osteoporosis. N Engl J Med 1990;323:73–9.

    Google Scholar 

  17. Pocock NA, Eberl S, Eisman JA, Yeates MG, Sambrook PN, Freund J, Duncan A. Dual-photon bone densitometry in normal Australian women: A cross-sectional study Med J Aust. 1987;146:293–7

    Google Scholar 

  18. Pocock NA, Eisman JA, Mazess RB, Sambrook PN, Yeates MG, Freund J. Bonemineral density in Australia compared with the United States. J Bone Miner Res 1988;3:601–4.

    Google Scholar 

  19. Kelly PJ, Twomey L, Eisman JA, Sambrook PN. Sex differences in peak adult bone mineral density. J Bone Miner Res 1990;5:1169–75.

    Google Scholar 

  20. Hui SL, Slemenda CW, Johnston CC. The contribution of bone loss to postmenopausal osteoporosis. Osteoporosis Int 1990;1:30–4.

    Google Scholar 

  21. Angus RM, Sambrook PN, Pocock NA, Eisman JA. Dietary intake and bone mineral density. Bone Miner 1988;4:265–77.

    Google Scholar 

  22. Pocock NA, Eisman JA, Kelly PJ, Sambrook PN, Yeates MG. Effects of tobacco use on axial and appendicular bone mineral density. Bone 1989;10:329–31.

    Google Scholar 

  23. Kroner B, Tondevold E, Toft B, Berthelssen B, Pors Nielson S. Bone mass of the axial and the appendicular skeleton in women with Colles' fracture: its relation to physical activity. Clin Physiol 1982;2:147–57.

    Google Scholar 

  24. Aloia JF, Vaswani AN, Yeh JK, Colin SH. Premenopausal bone mass is related to physical activity. Arch Intern Med 1988;148:121–3.

    Google Scholar 

  25. Orwoll ES, Ferar J, Oviatt SK, McClung MR, Huntington K. The relationship of swimming exercise to bone mass in men and women. Arch Intern Med 1989;149:2197–200.

    Google Scholar 

  26. Pocock NA, Eisman JA, Gwinn TH, Sambrook PN, Kelly P, Freund J, Yeates MG. Muscle strength, physical fitness and weight but not age predict femoral neck bone mass. J Bone Miner Res 1989;4:441–8.

    Google Scholar 

  27. Chow R, Harrison JE, Notarius C. Effect of two randomised exercise programmes on bone mass in healthy postmenopausal women. BMJ 1987;295:1441–4.

    Google Scholar 

  28. Cavanaugh DJ, Cann CE. Brisk walking does not stop bone loss in postmenopausal women. Bone 1988;9:201–4.

    Google Scholar 

  29. Dalsky GP, Stocke KS, Ehsani AA, Slatopolsky E, Lee WC, Birge SJ. Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med 1988;108:824–8.

    Google Scholar 

  30. Bevier WC, Wiswell RA, Pyka G, Kozak KC, Newhall KM, Marcus R. Relationship of body composition, muscle strength, and aerobic capacity to bone mineral density in older men and women. J Bone Miner Res 1989;4:421–32.

    Google Scholar 

  31. Sinaki M, McPhee MC, Hodgson SF, Merritt JM, Offord KP. Relationship between bone mineral density of spine and strength of back extensors in health postmenopausal women. Mayo Clin Proc 1986;61:116–22.

    Google Scholar 

  32. Lanyon LE. Function strain as a determinant for bone remodelling. Calcif Tissue Int 1984;36:S56-S61.

    Google Scholar 

  33. Whalen RT, Carter Dr. Influence of physical activity on the regulation of bone density. J Biomech 1988;21:825–37.

    Google Scholar 

  34. Smith El, Gilligan C, McAdam M, Ensign CP, Smith PE. Deterring bone loss by exercise intervention in premenopausal and postmenopausal women. Calcif Tissue Int 1989;44:312–21

    Google Scholar 

  35. Gleeson PB, Protas EJ, LeBlanc AD, Schneider VS, Evans HJ. Effect of weight lifting of bone density in premenopausal women. J Bone Miner Res 1990;5:153–8.

    Google Scholar 

  36. Sinaki M, Wahner HW, Offord KP, Hodgson SF. Efficacy of nonloading exercises in prevention of vertebral bone loss in postmenopausal women. Mayo Clin Proc 1989;64:762–9.

    Google Scholar 

  37. Cavanaugh DJ, Cann CE. Brisk walking does not stop bone loss in postmenopausal women. Bone 1988;9:201–4.

    Google Scholar 

  38. Prince R, Smith M, Price R, Lawson N, Dick I, Harris M. Screening followed by a randomized placebo controlled study of osteoporosis prevention. Bone Miner 1990;10:S304.

    Google Scholar 

  39. Smith DA, Nance WE, Wong Kang K, Christian JC, Johnston CC Jr. Genetic factors in determining bone mass. J Clin Invest 1973;52:2800–8.

    Google Scholar 

  40. Moller M, Horman A, Harvarld B, Hauge M, Henningsen K, Nordin BEC. Metacarpal morphometry in monozygotic and izygotic elderly twins. Calif Tissue Res 1978;25:197–201.

    Google Scholar 

  41. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S. Genetic determinants of bone mass in adults: A twin study. J Clin Invest 1987;80:706–10.

    Google Scholar 

  42. Dequeker J, Nijs J, Verstateten A, Geusens P, Gevers G. Genetic determinants of bone mineral content at the spine and the radius: a twin study. Bone 1987;8:207–9.

    Google Scholar 

  43. Seeman E, Hopper JL, Bach LA, et al. Reduced bone mass in daughters of women with osteoporosis. N Engl J Med 1989;320:554–8.

    Google Scholar 

  44. Christain JC, Yu P-L, Slemenda CW, Johnston CC Jr. Heritability of bone mass: a longitudinal study in aging men. Am J Hu M Genet 1989;44:429–33.

    Google Scholar 

  45. Lesage R, Simoneau JA, Jobin J, LeBlanc J, Bouchard C. Familial resemblance in maximal heart rate, blood lactate and aerobic power. Hum Hered 1985;35:182–9.

    Google Scholar 

  46. Montoye HJ, Gayle R. Familial relationships in maximal oxygen uptake. Hum Biol 1978:50:241–9.

    Google Scholar 

  47. Bouchard C, Lesage R, Lortie G, et al. Aerobic performance in brothers, dizygotic and monzygotic twins. Med Sci Sports Exerc 1986;18:639–46.

    Google Scholar 

  48. Slemenda CW, Johnston CC, Hui SL. Patterns of bone loss an dphysiologic growing [abstract 363]. In: Third International Symposium on Osteoporosis, 1990.

  49. Fisher EC, Nelson ME, Frontera WR, Tuksoy RN, Evans WJ. Bone mineral content and levels of gonadotropins and estrogens in amenorrheic running women. J Clin Endocrino Metab 1986;62:1232–6.

    Google Scholar 

  50. Drinkwater BL, Bruemner B, Chestnut CH III. Menstrual history as a determinant of current bone density in young athletes. JAMA 1990;263:545–8.

    Google Scholar 

  51. Bilanin JE, Blanchard MS, Russek-Cohen E. Lower vertebral bone density in male long distance runners. Med Sci Sports Exerc 1989;21:66–70.

    Google Scholar 

  52. Van Beresteijn EC, van't Hof MA, de Waard H, Raymakers JA, Duursma SA. Relation of axial bone mass to habitual calcium intake and to cortical bone mass in healthy postmenopausal women. Bone 1990;1:7–13.

    Google Scholar 

  53. Riggs BL, Wahner HW, Melton LJ, Richelson LS, Judd HL, O'Fallon WM. Dietary calcium intake and rates of bone loss in women. J Clin Invest 1987;80:979–82.

    Google Scholar 

  54. Stevenson JC, Lees B, Cust MP, Ganger KF. Determinants on bone density in normal women: risk factors for future osteoporosis. BMJ 1989;298:924–8.

    Google Scholar 

  55. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyown N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323:878–83.

    Google Scholar 

  56. Miller JZ, Slemenda CW, Johnston CC. Positive relationship between calcium intake and bone mass: A co-twin study [abstract 395] In: Third International symposium on Osteoporosis, 1990.

  57. Kelly PJ, Pocock NA, Sambrook PN, Eisman JA. Dietary calcium, sex hormonesand bone mineral density in normal men. BMJ 1990;300:1361–4.

    Google Scholar 

  58. Heaney RP, Davies KM, Recker RR, Packard PT. Long-term consistency of nutrient intakes in humans. J Nutr 1990;120:869–75.

    Google Scholar 

  59. Cumming RG. Calcium intake and bone mass:a quantitative review of the evidence. Calci Tissue Int 1990;47:194–201.

    Google Scholar 

  60. Sambrook PN, Eisman JA, Champion GD, Yeates MG, Pocock NA, Eberl S. Determinants of axial bone loss in rheumatoid arthritis. Arthritis Rheum 1987;30:721–8.

    Google Scholar 

  61. Kelly PJ, Sambrook PN, Eisman JA. The interaction of genetic and environmental influences on peak bone density. Osteoporosis In 1990;1:56–60.

    Google Scholar 

  62. Kelly PJ, Hopper JL, Macaskill GT, Pocock NA, Sambrook PN, Eisman JA. Genetic factors in bone turnover. J Clin Endocrinol Metab 1991;72:808–14.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone and Mineral Research Division, Garvan Institute of Medical Research, St. Vincents's Hospital, Sydney, Australia

    J. A. Eisman1, P. J. Kelly, N. A. Morrison, R. Yeoman, J. Birmingham & P. N. Sambrook

  2. Department of Nuclear Medicine, St. Vincent's Hospital, Sydney, Australia

    N. A. Pocock

Authors
  1. J. A. Eisman1
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. J. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. A. Morrison
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. A. Pocock
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Yeoman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Birmingham
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. N. Sambrook
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eisman1, J.A., Kelly, P.J., Morrison, N.A. et al. Peak bone mass and osteoporosis prevention. Osteoporosis Int 3 (Suppl 1), 56–60 (1993). https://doi.org/10.1007/BF01621865

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01621865

Keywords

Search

Navigation